
Rockville, Md. -- The Food and Drug Administration (FDA) just approved the veterinary drug Prascend (pergolide mesylate for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (PPID or Equine Cushing's disease) in horses.

